Carbone Pp
Impact in
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Lung Cancer Research Studies
- Viral-associated cancers and disorders
- Pathology and Forensic Medicine top 10%
- Lymphoma Diagnosis and Treatment
Papers in
-
- Lung Cancer Treatments and Mutations 6
- Oncology 11
- Cancer Treatment and Pharmacology 8
- Colorectal Cancer Treatments and Studies 1
- Co-authors
- Owens Ah (3 shared papers)J Edmonson (1 shared paper)Marvin A. Schneiderman (1 shared paper)Holland Jf (2 shared papers)Charles L. Spurr (1 shared paper)Bruce I. Shnider (1 shared paper)Joseph Scotto (1 shared paper)Moertel Cg (2 shared papers)
- Journals
- Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) (3 papers)PubMed (25 papers)
- Partner nations
- United States
In The Last Decade
Carbone Pp
28 papers receiving 440 citations
Peers
Comparison fields: 5 of 72
- Oncology 270
- Pathology and Forensic Medicine 137
- Genetics 67
- Pulmonary and Respiratory Medicine 170
- Hematology 53
Countries citing papers authored by Carbone Pp
This map shows the geographic impact of Carbone Pp's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carbone Pp with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carbone Pp more than expected).
Fields of papers citing papers by Carbone Pp
This network shows the impact of papers produced by Carbone Pp. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carbone Pp. The network helps show where Carbone Pp may publish in the future.
Co-authors
The 25 scholars most cited alongside Carbone Pp, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Clinical trials with 1,3-bis(2-chloroethyl)-1-nitrosourea, NSC-409962. | 1965 | 181 |
| 2 | Management of patients with malignant lymphoma: a comparative study with cyclophosphamide and vinca alkaloids. | 1968 | 108 |
| 3 | Chemotherapy of gastric and pancreatic carcinoma: a controlled evaluation of combinations of 5-fluorouracil with nitrosoureas and "lactones". | 1979 | 28 |
| 4 | Eastern Cooperative Oncology Group studies with DTIC (NSC-45388). | 1976 | 27 |
| 5 | Comparative trial of adriamycin and 5-fluorouracil in advanced prostatic cancer--progress report. | 1977 | 24 |
| 6 | EFFECT OF THORACIC DUCT LYMPH DRAINAGE ON THE IMMUNE RESPONSE IN MAN. | 1965 | 18 |
| 7 | Adriamycin in the treatment of far-advanced lung cancer. | 1976 | 15 |
| 8 | Phase II study of vinblastine, methyl-CCNU, and medroxyprogesterone in advanced renal cell cancer. | 1978 | 15 |
| 9 | Medical treatment for advanced breast cancer. | 1978 | 14 |
| 10 | Elevated plasma levels of a hydroxyproline-containing protein in Hodgkin's disease and their relation to disease activity. | 1966 | 13 |
| 11 | Phase II study of adriamycin and bleomycin in patients with multiple myeloma. | 1978 | 13 |
| 12 | Implications of the 99mTc diphosphonate bone scan on treatment of primary breast cancer. | 1977 | 11 |
| 13 | Clinical trial of vinblastine in multiple myeloma. | 1963 | 8 |
| 14 | Amplification of colony stimulating activity in human serum by interaction with CSA from other sources. | 1975 | 8 |
| 15 | Effectiveness of methyl-GAG (NSC-32946) administered intramuscularly. | 1975 | 7 |
| 16 | Phase II evaluation of diglycoaldehyde, VP-16-213, and the combination of methyl-CCNU and beta-2'-deoxythioguanosine in previously treated patients with colorectal cancer: an Eastern Cooperative Oncology Group study (EST-1275). | 1979 | 7 |
| 17 | Immunologic studies in American patients with Burkitt-like lymphoma. | 1967 | 7 |
| 18 | Clinical trials with BCNU (NSC-409962) in malignant lymphomas by the Eastern Cooperative Oncology Group. | 1976 | 6 |
| 19 | Phase II study of methyl-CCNU in the treatment of advanced pancreatic carcinoma. | 1976 | 6 |
| 20 | Cisplatin, doxorubicin, cyclophosphamide, lomustine, and vincristine (PACCO) in the treatment of non-small cell bronchogenic carcinoma. | 1984 | 5 |
About Carbone Pp
Carbone Pp is a scholar working on Pulmonary and Respiratory Medicine, Oncology, Cancer Research, Pathology and Forensic Medicine and Molecular Biology, having authored 28 papers that have together received 548 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (8 papers), Lung Cancer Treatments and Mutations (6 papers), Lymphoma Diagnosis and Treatment (4 papers), Cancer, Hypoxia, and Metabolism (3 papers), Cancer, Lipids, and Metabolism (2 papers), Multiple Myeloma Research and Treatments (2 papers), Metabolism and Genetic Disorders (1 paper) and Colorectal Cancer Treatments and Studies (1 paper). The work is most often cited by research in Oncology (270 citations), Pathology and Forensic Medicine (137 citations), Genetics (67 citations), Pulmonary and Respiratory Medicine (170 citations) and Hematology (53 citations). Carbone Pp has collaborated with scholars based in United States. Frequent co-authors include Owens Ah, J Edmonson, Marvin A. Schneiderman, Holland Jf, Charles L. Spurr, Bruce I. Shnider, Joseph Scotto, Moertel Cg, P F Engstrom and Jacob Colsky. Their work appears in journals such as Munich Personal RePEc Archive (Ludwig Maximilian University of Munich) and PubMed.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.